Global Clinical Trial Disclosure and Data Transparency Conference

Learn about the latest global requirements in clinical trial disclosure and data transparency, share best practices, and engage in in-depth discussions on hot topics.

戻る Agenda

Session 9: Protecting Confidential Information in Summaries of Trial Results

Session Chair(s)

Robert Paarlberg, MS

Principal

Paarlberg & Associates LLC, United States

Global clinical data disclosure and transparency requirements and initiatives have resulted in massive amounts of clinical data in the public domain. Local county and regional data protection regulations safe guard personal identifiable information from public disclosure. This session will explore how patient identifiable data are being protected in this global clinical disclosure/transparency ecosystem.

Learning Objective : At the conclusion of this session, participants should be able to:
Discuss the interplay between disclosure/transparency requirements and country/regional data protection regulations
Identify stakeholder perspectives
Implement best practices

Speaker(s)

Protecting Confidentiality: Public and Patient Perceptions and Best Communication Practice

Behtash Bahador, MS

Center for Information and Study on Clinical Research Participation (CISCRP), United States

Director, Health Literacy

Common Challenges Under GDPR for Data Disclosure and Transparency

Michael A. DiMaio, JD

Ropes & Gray LLP, United States

Attorney

Anonymisation and Public Trust (Remote Presentation)

Brendan Barnes

EFPIA, Belgium

Director, Data Protection & IP